Migraine is a common, heterogeneous and heritable neurological disorder. Its pathophysiology is incompletely understood, and its genetic influences at the population level are unknown. In a population-based genome-wide analysis including 5,122 migraineurs and 18,108 non-migraineurs, rs2651899 (1p36.32, PRDM16), rs10166942 (2q37.1, TRPM8) and rs11172113 (12q13.3, LRP1) were among the top seven associations (P < 5 × 10 −6 ) with migraine. These SNPs were significant in a meta-analysis among three replication cohorts and met genome-wide significance in a meta-analysis combining the discovery and replication cohorts (rs2651899, odds ratio (OR) = 1.11, P = 3.8 × 10 −9 ; rs10166942, OR = 0.85, P = 5.5 × 10 −12 ; and rs11172113, OR = 0.90, P = 4.3 × 10 −9 ). The associations at rs2651899 and rs10166942 were specific for migraine compared with non-migraine headache. None of the three SNP associations was preferential for migraine with aura or without aura, nor were any associations specific for migraine features. TRPM8 has been the focus of neuropathic pain models, whereas LRP1 modulates neuronal glutamate signaling, plausibly linking both genes to migraine pathophysiology.
l e t t e r s
Nevertheless, the top SNPs were more significant than expected for the 95% confidence interval for the ordered test statistic under the null hypothesis and, except for one SNP, remained more significant after controlling for modest inflation of the test statistic (λ GC = 1.03; Supplementary Fig. 1 ). Seven independent loci had at least one SNP with P < 5 × 10 −6 . We selected the most significant SNP from each locus for further analysis ( Table 1 lists three SNPs which ultimately reached genome-wide significance; Supplementary Table 2 lists all SNPs). None of the seven SNPs was associated with non-migraine headache in the WGHS (all P > 0.05, N = 3,001 compared with 14,959 controls). The significance and magnitude of the associations of the seven SNPs with migrane were essentially unchanged in sensitivity analyses using (i) an allele frequency test, (ii) logistic regression without adjustment or (iii) logistic regression adjusted for clinical characteristics, eigenvector parameters for sub-European population structure or both (Supplementary Table 3 ). There was no evidence of non-additive modes of association with migraine for any of the top SNPs, and no SNPs in the entire genome-wide scan reached genome-wide significance in non-additive models (D.I.C. & M.S., data not shown). Finally, analysis performed with genotypes imputed for approximately 2.6 million SNPs in HapMap (release 22) 7 revealed the same top seven loci found with the genotyped SNPs.
We evaluated the seven SNPs in two additional population-based cohorts: the Dutch Genetic Epidemiology of Migraine study (GEM 8 ; 774 migraineurs and 942 non-migraineurs) and the German Study of Health in Pomerania (SHIP 9 ; 306 migraineurs and 2,260 nonmigraineurs), as well as in the previously reported clinic-based case-control samples from the International Headache Genetics Consortium (IHGC 5 ; 2,748 migraineurs and 10,747 populationbased controls), all with European ancestry (Supplementary Note). Genotyping failed for rs17172526 in both GEM and SHIP. The effect estimates for rs2651899, rs10166942 and rs11172113 were concordant in direction and magnitude among all replication cohorts with the effects in the WGHS (Table 1 and Supplementary Table 2 ; P = 0.03 for consistency of direction). Moreover, among the three replication cohorts, all seven SNPs were concordant between the WGHS and the IHGC, the latter of which is the largest replication cohort (P = 0.02 (0.5 7 × 3 replication cohorts)). In IHGC, there were nominally significant associations for rs2078371 and the three SNPs that had concordant effects in all three replication cohorts. rs10166942 in GEM and both rs2651899 and rs11172113 in SHIP were also nominally significant ( Table 1 and Supplementary Table 2) .
We then performed a meta-analysis of the results for the primary SNPs using a fixed-effects model with inverse-variance weighting. Combining only the replication cohorts, the meta-analysis supported association (P < 0.008 (0.05/6)) for the three fully concordant SNPs: rs2651899 (OR = 1.08, 95% CI 1.03-1.14, P = 4.2 × 10 −3 ), rs10166942 (OR = 0.84, 95% CI 0.79-0.91, P = 5.0 × 10 −6 ) and rs11172113 (OR = 0.90, 95% CI 0.85-0.95, P = 3.0 × 10 −4 ) (see Table 1 and Supplementary Table 4 ). There was no strong evidence of heterogeneity among the studies (all I 2 < 22%, P het > 0.28). Furthermore, all three SNPs met the genome-wide standards of significance in a metaanalysis combining the discovery cohort with the replication cohorts ( Table 1 ; all P ≤ 4.3 × 10 −9 ). None of the remaining SNPs reached either nominal significance in the meta-analysis of the replication cohorts or genome-wide significance in the meta-analysis combining all cohorts (Supplementary Table 4) .
All three replicating SNPs map within or near transcribed regions of known genes. rs2651899 at 1p36.32 is within the first intron of PRDM16 in a block of moderate linkage disequilibrium (LD) extending about 22 kb in the 5′ direction and about 25 kb in the 3′ direction (Fig. 1a) . The transcript for the second closest gene, ACTRT2, terminates 144 kb from rs2651899. rs10166942 at 2q37.1 is 950 bp 5′ to the transcription start site for TRPM8 in a block of moderate LD spanning approximately 168 kb. This LD block begins about 117 kb 5′ from the SNP and extends through TRPM8 (Fig. 1b) , a gene previously identified as a potential candidate for association with migraine in the IHGC cohort on the basis of sub-genome-wide significance 5 . The second closest gene, HJURP, is situated 61.9 kb from rs10166942. rs11172113 at 12q13.3 maps to the first intron of LRP1 in a gene-rich region that also includes the second closest gene, STAT6, 22.1 kb away (Fig. 1c) . At each of the three loci, only the primary SNP was retained l e t t e r s in stepwise model selection for association with migraine, suggesting the absence of additional, non-redundant or conditional associations (Online Methods).
As migraine is more prevalent in women, we examined the effects of the three replicating SNPs on migraine in the replication cohorts, which include both women and men, in contrast to the WGHS. In the meta-analysis of the six sex-specific strata among the three replication cohorts, effect estimates were comparable to the main analysis, which was not stratified by sex (compare Supplementary Table 5, left  and Table 1 ). Notably, the heterogeneity estimate (I 2 ) for rs10166942 increased from 0% to 45.8%, although neither the heterogeneity P value nor a potential sex effect at this SNP in the meta-regression was significant (P = 0.10 and P = 0.23, respectively; Supplementary Table 5, right). However, a potential sex interaction for rs10166942 may have been confounded by differences in study design and migraine ascertainment between IHGC (clinic based) and GEM and SHIP (both population based). A meta-analysis by sex strata restricted to the population-based studies revealed even greater heterogeneity for rs10166942 (I 2 = 67.2%, heterogeneity P value = 0.03; Supplementary Table 6, left). In the meta-regression of this SNP in these two studies alone, the association with migraine suggested a significant sex interaction (P = 0.004) and essentially no evidence of association in men (OR = 1.08, 95% CI 0.85-1.38, P = 0.52; Supplementary Table 6, right). The potential differential association according to sex did not appear to be related to estrogen receptor 1 (encoded by ESR1), as there was no interaction between rs10166942 and ESR1 SNPs in WGHS, including SNPs associated with other clinical traits in other studies (Online Methods and data not shown). Similarly, none of the other primary SNPs showed an interaction with ESR1 SNPs (data not shown).
We investigated whether there was evidence for a disproportionate association of the three genome-wide significant SNPs from the meta-analysis with migraine aura status and features recognized by International Headache Society diagnostic criteria (unilateral pain location, pulsating pain quality, sensitivity to light or sound, attack duration, nausea and/or vomiting, aggravation by physical activity and inhibition of physical activity; Online Methods). None of these associations was more significant than for overall migraine (Supplementary Table 7) . Moreover, the allele frequency differences of the three SNPs between migraineurs with or without each of the features were not significant enough to overcome correction for multiple hypotheses testing, although some met nominal significance (Supplementary Table 8 ). In contrast, rs2651899 and rs10166942 (but not rs11172113) were significantly associated with migraine compared to non-migraine headache (rs2651899, OR = 1.12, 95% CI 1.05-1.20, P = 5 × 10 −4 ; and rs10166942, OR = 0.90, 95% CI 0.82-0.98, P = 0.01) with effects similar to the association of migraine compared to non-migraine controls, reinforcing their specificity for migraine (Supplementary Table 9 , compare with Table 1 ).
TRPM8 encodes a sensor for cold and cold-induced burning pain 10 , which is primarily expressed in sensory neurons and dorsal root ganglion neurons 11 . Members of the mammalian TRP superfamily are channels activated by stimuli of chemo-and somato-sensation. TRPM8 particularly is a target in animal models of neuropathic pain 12 . As migraine shares some characteristics with neuropathic pain disorders 13 , TRPM8 could be a pathophysiological link between both pain syndromes.
LRP1 is expressed in many tissues including brain and vasculature 14 . As a member of the lipoprotein receptor family, it serves as a sensor of the extracellular environment and also modulates synaptic transmission. LRP1 protein and glutamate (NMDA) receptors are co-localized on neurons and interact. This integrates well with findings from the previous GWAS in migraine reporting a genetic variant implicated in glutamate homeostasis 5 as well as with recent pharmacological approaches to migraine targeting glutamate receptors 15 .
A potential role of PRDM16 in migraine is unclear. PRDM16 was originally identified near a chromosomal breakpoint associated with myelodysplastic syndrome and acute myeloid leukemia 16 , but subsequent research has focused on its transcriptional role in brown fat development 17 . Structurally, PRDM16 contains two arrays of C2H2 zinc-finger domain repeats, which are often linked to transcriptional activity; PRDM16 also contains a putative SET domain, which is a conserved region among histone lysine methyltransferases.
Our findings may be compared with the recent GWAS reporting an association of rs1835740 at 8q22.1 with migraine, especially migraine with aura 5 . The nearby candidate genes PGCP and MTDH are involved in glutamate homeostasis, consistent with current concepts of migraine pathophysiology. However, in the WGHS, rs1835740 was neither associated with overall migraine (P = 0.22) nor migraine with or without aura separately (data not shown). Similarly, across the entire region, no SNP reached locus-wide significant thresholds for association with migraine, and there was no evidence of stronger associations with migraine with aura than without aura (Supplementary Fig. 2) . The most significant SNP for association with migraine in the WGHS was rs1864729 (OR = 1.15, 95% CI 1.06-1.25, P = 0.001). The differential findings between the current and the previous study 5 may partly relate to the differences in migraine ascertainment (see also the analysis of sex interaction above).
There are three major implications of our study. First, we have identified three SNPs with genome-wide significant association for common migraine at the population level. Two of the SNPs significantly distinguish migraine from non-migraine headache. In addition, the association of rs10166942 may be stronger among women, which may be related to but would not explain the higher prevalence of migraine in women. Second, although one new locus (LRP1) supports prevailing (glutamatergic) concepts of neurotransmitter pathways in migraine 4 , we also identified a second new locus (TRPM8) explicitly implicated in a pain related pathway. The functional role of the third locus (PRDM16) pathway is still unknown. Last, whereas some studies have focused on differences between migraine with and without aura 4 , our results suggest a shared pathophysiology among common types of migraine (Supplementary Tables 7,8) .
Ongoing large GWAS will continue to identify additional genetic risk variants for migraine and further delineate the pathophysiological basis of migraine. Meanwhile, the three new loci identified in the present work provide hypotheses for immediate further exploration.
URLs. R, http://www.r-project.org/; Metal, http://www.sph.umich. edu/csg/abecasis/Metal/index.html.
MeThOdS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. 
Note: Supplementary information is available on the Nature Genetics website.
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